Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU for the Development of Precision Immuno-Oncology Therapeutics 2025-08-28 09:54
AIM Vaccine Forecasts Surge in Stock Performance: Innovations Reinforce Leadership in Vaccine Sector 2025-08-28 07:45
Fosun International: Total Revenue for the First Half of 2025 Reaches RMB87.28 Billion, Industrial Operation Profit Amounts to RMB3.15 Billion 2025-08-27 20:40
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment 2025-08-26 14:29
Basecare Medical (02170.HK) Gems Culture Medium Receives First Approval from NMPA, Advancing the Localization of Assisted Reproductive Fluids 2025-08-26 11:47
Neopharma Technologies and Orient Gene Partner to Digitize Healgen® Drug Test Portfolio Globally with NEOVAULT® 2025-08-26 02:10
Henlius Keeps Steady Growth in H1 2025: Overseas Product Profits Soar 200%+, Innovation Fuels Global Reach 2025-08-25 21:18
Everest Medicines Announces Participation in September Investor Conferences 2025-08-25 20:57
Acceleration in Clinical Development! Leads Biolabs' LBL-034 Dosed First Patient in Phase Ⅱ Trial 2025-08-25 18:27
Pulnovo Medical Names Dr. Francis Duhay as Global Chief Medical Officer 2025-08-25 16:42
Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy 2025-08-25 15:43
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts 2025-08-25 12:01
Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform 2025-08-22 18:14
MALAYSIA SHOWCASES HEALTHCARE EXCELLENCE IN CAMBODIA, DRIVING MOMENTUM TOWARDS MYMT 2026 2025-08-22 11:00
Biosyngen Unveils Innovative Strategies for Next-Generation TIL Therapies in Asia Bio 2025 Singapore 2025-08-22 09:55
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results 2025-08-21 18:02
Debut of new form of health supplement product! WCC biomedical collaborate with Synmosa toward the niche market! 2025-08-21 09:23
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth 2025-08-21 08:23
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies 2025-08-20 08:00
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC 2025-08-19 20:09
1 9 10 11 12 13 280